Campaign India Team
Jul 08, 2022

Rohit Shetty earns profit on his Olx Autos sale through Sharman Joshi

Watch the film conceptualised by Lowe Lintas here

The pre-owned automobile company, Olx Autos, has rolled out the final edition of its ‘Shetty ke Car-Naame’ campaign titled ‘normal car’ featuring film director Rohit Shetty and actor Sharman Joshi. 

 

Conceptualised by Lowe Lintas, the film showcases Joshi, who plays an Olx Autos employee breaking into Shetty’s movie set and trying to figure out what’s special about Shetty’s stunt car. Shetty tells Joshi that his films also include everyday cars that don't have any special qualities. Even though the car Shetty wishes to sell doesn’t possess any stunt-worthy capabilities, Joshi delights him by offering a profitable price for his Olx Autos sale. 

 

CREDITS: 

 

Creative agency: Lowe Lintas

Talent agency: Wavemaker 

Creative: Vasudha Misra, Sidhant Mago, Suhrid Sethumadhavan, Kuhu Nagpal, Chakori Prasad

Account management: Tanul Bhartiya, Pratik Adhikari, Prasoon Saxena

Planning: Anurag Prasad, Punit Singh

Production house: HMF (Happy Making Films)

Director: Apoorv Singh Karki

Associate director: Anirudh Thorat

Producer: Ashish Bhatia

Source:
Campaign India

Related Articles

Just Published

3 hours ago

Scroll less, sniff out the truth first

Bark Out Loud’s new campaign warns pet parents: don’t swap science for social hearsay when it comes to pet care.

4 hours ago

Where are India’s women at the global table?

Despite talent and tenacity, Women Inspiring Network’s founder rues that Indian women remain underrepresented on global stages like Cannes and Davos. Networks, not just skills, are the missing link.

1 day ago

Adobe’s APAC CMO: ‘There is a balance between ...

Duncan Egan weighs-in on how much AI should be relied upon and how much B2B marketing is changing, in his own role as a marketer to marketers.

1 day ago

When the pavement becomes a cancer ward

A gut-punching film from St. Jude India spotlights how unsafe shelter, not treatment, threatens young cancer patients’ survival in metro cities.